Factor V Leiden (R506Q) Mutation, Blood
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Factor V Leiden mutation testing should be reserved for patients with clinically suspected thrombophilia and: 1) APC-resistance proven or suspected by a low or borderline APC-resistance ratio, or 2) a family history of factor V Leiden.
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Tests for R506Q mutation only.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Direct Mutation Analysis
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
APC resistance mutation
Factor V Leiden mutation